Evercore ISI Starts Rapt Therapeutics (RAPT) at Outperform, 'risk reward is very good at these levels'
Tweet Send to a Friend
(Updated - February 16, 2024 6:23 AM EST)
Evercore ISI analyst Umer Raffat initiates coverage on Rapt Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Umer Raffat initiates coverage on Rapt Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
